Literature DB >> 7964499

A labile transcriptional repressor modulates endotoxin tolerance.

K E LaRue1, C E McCall.   

Abstract

Tolerance to bacterial lipopolysaccharide (LPS, endotoxin) is an adaptive cellular process whereby exposure to endotoxin induces a subsequent hyporesponsive state characterized by decreased levels of LPS-induced cytokine mRNA and protein. We demonstrate, in a human promonocytic cell line, THP-1, that endotoxin tolerance is manifested by decreased LPS-induced interleukin 1 beta (IL-1 beta) transcription. Inhibition of protein synthesis reverses the tolerant phenotype by inducing transcription of IL-1 beta in the absence of a second stimulus. These results indicate that a labile protein contributes to the endotoxin-tolerant phenotype, and that this factor acts in a dominant repressive manner to inhibit the activity of existing transcription factors. We provide further data that cellular expression of I kappa B-alpha correlates with downregulated IL-1 beta gene expression during endotoxin tolerance, implicating I kappa B-alpha as a potential candidate for the labile repressor identified herein.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7964499      PMCID: PMC2191765          DOI: 10.1084/jem.180.6.2269

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  34 in total

1.  Adaptation to bacterial lipopolysaccharide controls lipopolysaccharide-induced tumor necrosis factor production in rabbit macrophages.

Authors:  J C Mathison; G D Virca; E Wolfson; P S Tobias; K Glaser; R J Ulevitch
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

2.  Endotoxin-macrophage interaction: post-translational regulation of tumor necrosis factor expression.

Authors:  S H Zuckerman; G F Evans; Y M Snyder; W D Roeder
Journal:  J Immunol       Date:  1989-08-15       Impact factor: 5.422

3.  A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation.

Authors:  G Shaw; R Kamen
Journal:  Cell       Date:  1986-08-29       Impact factor: 41.582

4.  Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B.

Authors:  S Ghosh; D Baltimore
Journal:  Nature       Date:  1990-04-12       Impact factor: 49.962

5.  Transcriptional induction by interferon. New protein(s) determine the extent and length of the induction.

Authors:  A C Larner; A Chaudhuri; J E Darnell
Journal:  J Biol Chem       Date:  1986-01-05       Impact factor: 5.157

6.  Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop.

Authors:  J Hiscott; J Marois; J Garoufalis; M D'Addario; A Roulston; I Kwan; N Pepin; J Lacoste; H Nguyen; G Bensi
Journal:  Mol Cell Biol       Date:  1993-10       Impact factor: 4.272

7.  A CRE/ATF-like site in the upstream regulatory sequence of the human interleukin 1 beta gene is necessary for induction in U937 and THP-1 monocytic cell lines.

Authors:  J G Gray; G Chandra; W C Clay; S W Stinnett; S A Haneline; J J Lorenz; I R Patel; G B Wisely; P J Furdon; J D Taylor
Journal:  Mol Cell Biol       Date:  1993-11       Impact factor: 4.272

8.  I kappa B: a specific inhibitor of the NF-kappa B transcription factor.

Authors:  P A Baeuerle; D Baltimore
Journal:  Science       Date:  1988-10-28       Impact factor: 47.728

9.  Lipopolysaccharide induces hyporesponsiveness to its own action in RAW 264.7 cells.

Authors:  G D Virca; S Y Kim; K B Glaser; R J Ulevitch
Journal:  J Biol Chem       Date:  1989-12-25       Impact factor: 5.157

10.  Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors.

Authors:  M A Collart; D Belin; J D Vassalli; S de Kossodo; P Vassalli
Journal:  J Exp Med       Date:  1986-12-01       Impact factor: 14.307

View more
  33 in total

Review 1.  Gene-specific epigenetic regulation in serious infections with systemic inflammation.

Authors:  Charles E McCall; Barbara Yoza; Tiefu Liu; Mohamed El Gazzar
Journal:  J Innate Immun       Date:  2010-04-27       Impact factor: 7.349

2.  Mechanistic role of microRNA-146a in endotoxin-induced differential cross-regulation of TLR signaling.

Authors:  Md A Nahid; Minoru Satoh; Edward K L Chan
Journal:  J Immunol       Date:  2010-12-22       Impact factor: 5.422

3.  Facultative heterochromatin formation at the IL-1 beta promoter in LPS tolerance and sepsis.

Authors:  Barbara K Yoza; Charles E McCall
Journal:  Cytokine       Date:  2011-02       Impact factor: 3.861

Review 4.  Gene silencing in severe systemic inflammation.

Authors:  Charles E McCall; Barbara K Yoza
Journal:  Am J Respir Crit Care Med       Date:  2007-01-25       Impact factor: 21.405

Review 5.  RelB: an outlier in leukocyte biology.

Authors:  Patrick Millet; Charles McCall; Barbra Yoza
Journal:  J Leukoc Biol       Date:  2013-08-06       Impact factor: 4.962

6.  G9a and HP1 couple histone and DNA methylation to TNFalpha transcription silencing during endotoxin tolerance.

Authors:  Mohamed El Gazzar; Barbara K Yoza; Xiaoping Chen; Jean Hu; Gregory A Hawkins; Charles E McCall
Journal:  J Biol Chem       Date:  2008-09-22       Impact factor: 5.157

7.  MicroRNA-146a regulates both transcription silencing and translation disruption of TNF-α during TLR4-induced gene reprogramming.

Authors:  Mohamed El Gazzar; Ashley Church; Tiefu Liu; Charles E McCall
Journal:  J Leukoc Biol       Date:  2011-05-11       Impact factor: 4.962

8.  Dynamic and selective nucleosome repositioning during endotoxin tolerance.

Authors:  Mohamed El Gazzar; Tiefu Liu; Barbara K Yoza; Charles E McCall
Journal:  J Biol Chem       Date:  2009-11-09       Impact factor: 5.157

9.  Low-dose lipopolysaccharide (LPS) pretreatment of mouse macrophages modulates LPS-dependent interleukin-6 production in vitro.

Authors:  N Hirohashi; D C Morrison
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

10.  AMP-Activated Protein Kinase and Glycogen Synthase Kinase 3β Modulate the Severity of Sepsis-Induced Lung Injury.

Authors:  Zhongyu Liu; Nathaniel Bone; Shaoning Jiang; Dae Won Park; Jean-Marc Tadie; Jessy Deshane; Cilina Ann Rodriguez; Jean-Francois Pittet; Edward Abraham; Jaroslaw W Zmijewski
Journal:  Mol Med       Date:  2015-11-30       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.